Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）

This study is testing a new drug called HN2301 in patients with autoimmune diseases — particularly lupus (SLE) — whose disease remains active despite standard treatment. **You may be eligible if...** - You are between 18 and 69 years old - You have a confirmed lupus (SLE) diagnosis for at least 6 months - Your disease is still active or has flared up despite being on a stable treatment regimen for at least 8 weeks - Your current medications include anti-inflammatories, antimalarials, steroids, or immunosuppressants **You may NOT be eligible if...** - You have severe organ damage from lupus (such as severe kidney or brain involvement) - You have a serious active infection - You are pregnant or breastfeeding - You have had recent major surgery or other cancer Talk to your doctor to see if this trial is right for you.